Izuralimab Antibody
Izuralimab is a bispecific IgG1 antibody designed to simultaneously target the immune checkpoint proteins ICOS (CD278) and PD-1. This dual-targeting mechanism makes it a valuable tool for investigating T-cell activation and exhaustion in both in vitro cellular assays and in vivo models of cancer immunology.
Product Specifications
Target
PD-1/PD-L1
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog